Betulalbuside A exhibits significant anti-inflammatory activity by inhibiting the production of pro-inflammatory mediators such as nitric oxide and cytokines in macrophage cells. It has been studied for its potential in managing chronic inflammatory conditions due to its ability to suppress key signaling pathways like NF-κB. Additionally, it shows moderate antioxidant properties, which may contribute to its protective effects in cellular models of oxidative stress. Research also suggests possible neuroprotective applications, as it demonstrates activity in models related to neuronal inflammation and degeneration. Its natural origin and biological profile make it a candidate for further development in therapeutic agents targeting inflammation-related diseases.